News
When glucagon-like peptide-1 receptor agonists (GLP-1s) like semaglutide (Wegovy) and liraglutide (Saxenda) were approved for ...
People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...
Experts highlight interventions to support muscle and nutrient preservation during GLP-1 treatment and offer practical ...
West Pharmaceutical stock was climbing 19% on Thursday, putting it on track for the strongest single-day percentage increase ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...
In a study on people with obesity and asthma, researchers saw “significant” improvements in the asthma scores of people who ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...
Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...
Pediatric endocrinologist Dr. Casey Berman says GLP-1s may help children reduce their risk of developing serious health ...
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results